Riskpilot← Back to searchSign inGet full accessCederborgskliniken AB
ABActiveOrg 5592303209Askims Fornborgsväg 20Medical specialists activities · NACE 8622Est. 20190 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
56.7%
Financial strength
Net profit 2024
SEK -2K
-100% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | — |
| Net profit | SEK -2K | -100% |
| Total assets | SEK 104K | -67% |
| Equity | SEK 59K | -3% |
| Employees | 0 | — |
Legal name
Cederborgskliniken AB
Org number
5592303209
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
9 december 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva allmän läkarvård inom öppenvård samt hälso- och skönhetsvård.
Address
Askims Fornborgsväg 20
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 258 | 288 | 115 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −258 | 203 | 108 | — | −1 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −258 | 203 | 108 | 0 | −1 |
| Net financials | −11 | −19 | −8 | −1 | −1 |
| Profit before tax | −269 | 184 | 100 | −1 | −2 |
| Tax | −0 | −0 | −3 | −0 | −0 |
| Net profit | −269 | 184 | 97 | −1 | −2 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 302 | 339 | 318 | 318 | 104 |
| Equity | −219 | −36 | 62 | 61 | 59 |
| Long-term debt | 306 | 93 | 0 | 0 | 0 |
| Short-term debt | 215 | 281 | 256 | 257 | 45 |
| Total debt | 521 | 374 | 256 | 257 | 45 |
EBITDA margin
-100000.0%
This company
15.8%
Market median
-633011% vs market
20202024
Equity ratio
56.7%
This company
38.2%
Market median
+48% vs market
20202024
Return on equity
-3.4%
This company
18.4%
Market median
-118% vs market
20202024
Net profit margin
-200000.0%
This company
8.1%
Market median
-2469236% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.76×
This company
0.62×
Market median
+23% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cederborgskliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emre Roger Remelay | Board of Directors | 0 companies |
| Mohamed el Mohamed | Deputy Board Member | 0 companies |